Smart Contact Lenses Now Detect Disease Biomarkers Directly From Tears
Optical biosensors embedded in contact lenses can continuously monitor glucose, cortisol, and inflammatory markers in tear fluid without blood draws.
Summary
A 2025 review in ACS Sensors examines how optical biosensors integrated into contact lenses can noninvasively monitor disease biomarkers in tear fluid. Tear fluid contains measurable concentrations of glucose, electrolytes, cortisol, lactate, and inflammatory proteins that reflect both ocular and systemic health. Optical sensing mechanisms including fluorescence, photonic crystal resonance, and surface plasmon resonance offer high sensitivity without the enzyme instability of electrochemical systems. Fabrication advances such as inkjet printing, micropatterning, and 3D microfabrication enable precise sensor integration into biocompatible hydrogel lenses. The technology shows promise for monitoring diabetes, dry eye syndrome, glaucoma, and neurodegenerative diseases in real time at the point of care.
Detailed Summary
Over 2.2 billion people worldwide live with visual impairments, and many systemic diseases go undetected until advanced stages partly because current diagnostics require invasive, episodic testing. Contact lens biosensors offer a fundamentally different approach: continuous, noninvasive monitoring of tear fluid, a biofluid replenished at roughly 0.5 µL per minute that mirrors blood plasma composition and carries clinically actionable biomarkers.
This comprehensive review from Imperial College London and Sichuan University traces the evolution of contact lens sensors from early pHEMA hydrogel lenses in 1970 through the MEMS-enabled electrochemical sensors of the 2010s and into today's sophisticated optical platforms. The authors systematically compare electrochemical and optical approaches, concluding that optical methods—fluorescence, photonic crystal resonance, holographic gratings, FRET-based probes, and surface-enhanced Raman scattering (SERS)—provide superior sensitivity (nanomolar to picomolar range), easier multiplexing, and greater stability by avoiding enzyme degradation and hard-wired electronic interfaces.
Lens substrate selection is a central engineering challenge. Soft hydrogels and silicone hydrogels must maintain oxygen permeability, optical clarity, and biocompatibility while hosting embedded sensing elements. Fabrication strategies reviewed include inkjet printing for depositing sensing reagents at precise locations, micropatterning to create structured optical elements, and 3D microfabrication for internal microstructures. These approaches enable sensors to reside on lens surfaces, within intermediate layers, or inside internal microchannels.
The biomarker landscape covered is broad and clinically significant. Glucose monitoring in diabetics, electrolyte profiling (K⁺, Na⁺, Ca²⁺) for dry eye subtypes, matrix metalloproteinase detection for glaucoma, cortisol tracking for stress disorders, TNF-α measurement for Parkinson's disease, and lacryglobin as a cancer metastasis marker are all demonstrated with optically integrated systems at physiologically relevant concentrations. Multiplexed scleral lens sensors have simultaneously detected multiple tear ions, illustrating the platform's versatility.
Despite impressive progress, significant barriers to clinical translation remain. Background optical interference from the complex tear matrix, limited long-term sensor stability during extended wear, lack of wireless optical readout miniaturization, and absence of scalable manufacturing protocols are cited as key gaps. The authors call for investment in robust biorecognition chemistries, wireless readout integration, and standardized clinical validation frameworks to move these systems from proof-of-concept to everyday diagnostic tools.
Key Findings
- Optical sensors in contact lenses achieve nanomolar-to-picomolar sensitivity for tear glucose, cortisol, electrolytes, and inflammatory markers.
- Fluorescence, photonic crystal, and SERS-based mechanisms outperform enzyme electrochemical sensors in stability and multiplexing.
- Tear fluid biomarkers reflect systemic diseases including diabetes, Parkinson's disease, and cancer metastasis, not just ocular conditions.
- Inkjet printing, micropatterning, and 3D microfabrication enable precise, biocompatible integration of sensors into soft hydrogel lenses.
- Key unresolved challenges include optical background interference, long-term wear stability, and scalable wireless readout systems.
Methodology
This is a narrative review of the primary literature synthesizing advances in optical contact lens biosensor materials, fabrication techniques, sensing mechanisms, and target biomarkers. The authors compare electrochemical and optical sensing platforms using a radar-plot framework scoring sensitivity, usability, cost, real-time feasibility, and integration ease. No meta-analysis or statistical pooling was performed.
Study Limitations
As a review, the paper synthesizes proof-of-concept studies rather than reporting clinical trial data, so real-world performance in diverse patient populations remains unvalidated. Most described sensors have been tested in controlled laboratory or ex vivo tear fluid conditions, not in continuous on-eye human use. Challenges including background optical interference, sensor drift during extended wear, and lack of regulatory-grade manufacturing standards have not yet been resolved.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.